The biotech sector didn’t report any major transactions. The largest deal was the sale of Complete Genomics (NASDAQ: GNOM) to China-based BGI-Shenzhen for approximately $117.6 million, or $3.15 per share. The price represents an 18% premium to the prior day close. ...
Brought to you by www.DealSearchOnline.com November 5, 2012 Issue: Recent Health Care M&A Deals Third Quarter M&A Results Spotlight on: Long Term Care Webcast Calendar Recent Health Care M&A Deals Long Term Care Acquirer Target Price East Coast...
FOR IMMEDIATE RELEASE Stephen M. Monroe, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – November 8, 2012 – Over the last five-and-a-half years, the Great Recession, along with a general uncertainty regarding...
FOR IMMEDIATE RELEASE Stephen M. Monroe, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – November 7, 2012 – During the January 1, 2007 through June 30, 2012 period, a total of 432 transactions were recorded in...
FOR IMMEDIATE RELEASE Stephen M. Monroe, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – November 6, 2012 – A new three-and-a-half year biotechnology M&A report published by Irving Levin Associates, Inc....
As we mentioned, September nearly matched August in terms of the number of announced long-term care transactions, but all of them were under $100 million with the exception of the anticipated announcement by Health Care REIT (NYSE: HCN) regarding who would be the...